Hepatitis B Foundation: Hepatitis C and Hepatitis B Coinfection #hepatitis #b, #hepatitis #c, #coinfections, #co-infections, #liver #disease, #liver #cancer

Posted On Sep 24 2017 by

# Hepatitis C Coinfection Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections account for a substantial proportion of liver diseases worldwide. Because the two viruses share similar modes of transmission, co-infection with the two viruses is not uncommon, though the vast majority of those coinfected with HCV and HBV acquired these viruses through intravenous drug use, unscreened blood products, or exposure to dirty needles and unsterilized medical equipment The exact number of patients co-infected with HCV and HBV is unknown and may be underestimated because the hepatitis C virus can become the “dominant” liver virus, and reduces hepatitis …


Myopia: did you really understand what your eye doctor told you? #eye #disease, #eye #conditions, #refractive #error, #nearsightedness, #nearsighted #eyes, #shortsighted, #short-sighted, #eyecare, #eye #care, #optometry, #ophthalmology

Posted On Sep 22 2017 by

# MYOPIA (Nearsightedness) Did you really understand what your eye doctor told you?Excerpted from Taking Care of Your Eyes �2003-2005by Triad Communications myopia (mi-OH-pee-uh), nearsightedness.Refractive error. Focusing defect created by an overpowered eye, one that has too much optical power for its length. Light rays scoming from a distant object are brought to focus before reaching the retina. Nearsighted people see close-up objects clearly but distance vision is blurry. Corrected with a minus lens (spectacle or contact) to weaken the eye optically and permit clear distance vision. (From Dictionary of Eye Terminology . 4th ed, � 2001 by Triad Communications) …


Rare Disease Gene Therapy Biotechnology Company #aurobindo #pharma #news

Posted On Sep 19 2017 by

#biotechnology company # Company Audentes Therapeutics is a biotechnology company committed to the development and commercialization of innovative new gene therapy treatments for people with serious rare diseases. We are a focused, experienced and passionate team driven by the goal of improving the lives of patients. We currently have four programs in development: AT132 for the treatment of X-Linked Myotubular Myopathy (XLMTM), an ultra-rare, severe, debilitating disease that affects skeletal muscles in an estimated one in 50,000 newborn males worldwide, and is caused by mutations in the MTM1 gene AT342 for the treatment of Crigler-Najjar Syndrome (CN), a rare, congenital …


IWCC home page #workman #compensation #lawyer, #workers’ #compensation #workmens’ #compensation #work-related #injury #work-related #illness #industrial #accident #occupational #disease #illinois

Posted On Sep 6 2017 by

# IWCC Links Welcome Workers’ compensation is a no-fault system of benefits paid by employers to workers who experience work-related injuries or diseases. The Illinois Workers’ Compensation Commission resolves disputes between employees and employers regarding work-related injuries and illnesses. A case is first tried by an arbitrator, whose decision may be reviewed by a panel of three commissioners. Cases may then be appealed to the circuit court, Appellate Court, and Illinois Supreme Court. Like most court systems, the vast majority of disputes are resolved by settlement. Our staff will explain Commission procedures and case status information, but cannot answer specific …


Elant offers a full continuum of care including Retirement Community Living, Home Health Care and a Managed Long Term Care Plan #elant, #healthcare, #health #care, #nursing, #skilled #nursing, #skilled #nursing #home, #skilled #nursing #care, #nursing #home, #convalescence, #residential #care, #senior, #senior #care, #physical #therapy, #rehabilitation, #rehab, #occupational #therapy, #speech #therapy, #therapy, #assisted #living, #retirement #living, #assisted #living #facility, #respite #care, #caregivers, #care #giver, #retirement #community, #independent #living, #independent #living #facility, #senior #living, #senior #communities, #senior #assisted #living, #senior #housing, #geriatric #care, #long #term #care, #extended #care, #short #term #care, #short #term #rehabilitation, #post #acute #care, #sub #acute #care, #nursing #care, #memory #care, #dementia, #dementia #care, #alzheimer, #alzheimer #care, #alzheimer’s #patient, #alzheimer’s #disease, #hospice, #hospice #care, #end #of #life #care, #elant #nursing #home, #specialized #care, #adult #day #care, #adult #daycare, #adult #day #healthcare, #adult #day #health #care, #managed #care, #managed #long #term #care, #home #care, #home #health #care, #home #assistance, #care #at #home, #health #services, #rehabilitative #services, #rehab #center, #rehabilitation #center, #post #surgical #therapy, #post #hospital #care, #post #hospital #rehabilitation, #joint #replacement #therapy, #prosthetic #rehabilitation, #orthotic #rehabilitation, #cardiac #rehab, #cardiac #rehabilitation, #iv #therapy, #palliative #care, #incontinence #care, #ms, #multiple #sclerosis, #specialized #care, #eldercare, #new #york #nursing #homes, #orange #county #nursing #homes, #dutchess #county #nursing #homes, #westchester #county #nursing #homes, #westchester #nursing #homes, #nursing #homes #near #new #york #city, #elant #nursing #home, #hudson #valley #nursing #homes, #long #term #care, #long #term #care #facility, #long #term #care #facilities, #long #term #nursing #care, #elderly, #geriatric, #chronically #ill, #new #york, #orange #county, #dutchess #county, #rockland #county, #westchester #county, #westchester, #hudson #valley, #goshen, #newburgh, #beacon, #fishkill, #wappingers #falls, #briarcliff #manor, #senior #care #in #orange #county, #senior #care #in #dutchess #county, #senior #care #in #rockland #county, #senior #care #in #westchester #county, #senior #care #new #york, #senior #care #in #hudson #valley

Posted On Aug 26 2017 by

# Elant at Meadow Hill Whether your loved one requires full-time residential care or daytime care only, Elant at Meadow Hill is your community health care solution. Set on eight beautifully landscaped acres in a residential neighborhood, Elant at Meadow Hill s local setting offers convenience and comfort for families and residents. We re proud of Elant at Meadow Hill s delightful Kohl Corner, named in honor of our late friend and supporter George Bob Kohl. This professionally-designed, park-like area offers residents and families a soothing spot for quiet reflection or just enjoying time together. Utilizing a team approach, Elant …


Rare Disease Gene Therapy Biotechnology Company #biotechnology #jobs

Posted On Aug 11 2017 by

#biotechnology company # Company Audentes Therapeutics is a biotechnology company committed to the development and commercialization of innovative new gene therapy treatments for people with serious rare diseases. We are a focused, experienced and passionate team driven by the goal of improving the lives of patients. We currently have four programs in development: AT132 for the treatment of X-Linked Myotubular Myopathy (XLMTM), an ultra-rare, severe, debilitating disease that affects skeletal muscles in an estimated one in 50,000 newborn males worldwide, and is caused by mutations in the MTM1 gene AT342 for the treatment of Crigler-Najjar Syndrome (CN), a rare, congenital …


Rare Disease Gene Therapy Biotechnology Company #digital #pharma

Posted On Jul 26 2017 by

#biotechnology company # Company Audentes Therapeutics is a biotechnology company committed to the development and commercialization of innovative new gene therapy treatments for people with serious rare diseases. We are a focused, experienced and passionate team driven by the goal of improving the lives of patients. We currently have four programs in development: AT132 for the treatment of X-Linked Myotubular Myopathy (XLMTM), an ultra-rare, severe, debilitating disease that affects skeletal muscles in an estimated one in 50,000 newborn males worldwide, and is caused by mutations in the MTM1 gene AT342 for the treatment of Crigler-Najjar Syndrome (CN), a rare, congenital …


Rare Disease Gene Therapy Biotechnology Company #catalent #pharma #solutions

Posted On Apr 6 2017 by

#biotechnology company # Company Audentes Therapeutics is a biotechnology company committed to the development and commercialization of innovative new gene therapy treatments for people with serious rare diseases. We are a focused, experienced and passionate team driven by the goal of improving the lives of patients. We currently have four programs in development: AT132 for the treatment of X-Linked Myotubular Myopathy (XLMTM), an ultra-rare, severe, debilitating disease that affects skeletal muscles in an estimated one in 50,000 newborn males worldwide, and is caused by mutations in the MTM1 gene AT342 for the treatment of Crigler-Najjar Syndrome (CN), a rare, congenital …


Rare Disease Gene Therapy Biotechnology Company #bsp #pharma

Posted On Nov 8 2016 by

#biotechnology company # Company Audentes Therapeutics is a biotechnology company committed to the development and commercialization of innovative new gene therapy treatments for people with serious rare diseases. We are a focused, experienced and passionate team driven by the goal of improving the lives of patients. We currently have four programs in development: AT132 for the treatment of X-Linked Myotubular Myopathy (XLMTM), an ultra-rare, severe, debilitating disease that affects skeletal muscles in an estimated one in 50,000 newborn males worldwide, and is caused by mutations in the MTM1 gene AT342 for the treatment of Crigler-Najjar Syndrome (CN), a rare, congenital …


Rare Disease Gene Therapy Biotechnology Company #alkem #pharma

Posted On Oct 30 2016 by

#biotechnology company # Company Audentes Therapeutics is a biotechnology company committed to the development and commercialization of innovative new gene therapy treatments for people with serious rare diseases. We are a focused, experienced and passionate team driven by the goal of improving the lives of patients. We currently have four programs in development: AT132 for the treatment of X-Linked Myotubular Myopathy (XLMTM), an ultra-rare, severe, debilitating disease that affects skeletal muscles in an estimated one in 50,000 newborn males worldwide, and is caused by mutations in the MTM1 gene AT342 for the treatment of Crigler-Najjar Syndrome (CN), a rare, congenital …